- Home
- ASRT vs DRIO Comparison
ASRT vs DRIO Comparison
Compare ASRT & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASRT | DRIO |
|---|---|---|
| Founded | 1995 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.1M | 82.2M |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | ASRT | DRIO |
|---|---|---|
| Price | $9.94 | $10.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $45.00 | ★ $50.00 |
| AVG Volume (30 Days) | ★ 30.2K | 26.4K |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $137,354,000.00 | $24,732,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $20.02 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 9.22 | 7.29 |
| 52 Week Low | $7.71 | $5.94 |
| 52 Week High | $15.15 | $31.00 |
Technical Indicators
Market Signals| Indicator | ASRT | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 98.16 | 36.66 |
| Support Level | $0.61 | $11.93 |
| Resistance Level | $0.75 | $12.88 |
| Average True Range (ATR) | 0.10 | 0.75 |
| MACD | 0.58 | -0.21 |
| Stochastic Oscillator | 94.90 | 4.83 |
Price Performance
Historical ComparisonAbout ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.